Research Article. Buraimoh A.A 1 *, Shu aibu H.O. 1, Ojo S.A. 2 and Bako I.G Department of Veterinary Anatomy, Faculty of Veterinary Medicine,

Similar documents
Study of the Side effects profile of different antihypertensive drugs among the Hypertensive patient

INVIVO STUDY ON THE EFFICACY OF Vernonia amygdalina (BITTER LEAF) EXTRACT ON Ascaris lumbricoides, USING MICE

JMSCR Vol 05 Issue 03 Page March 2017

PRESCRIPTION PATTERN OF ANTI HYPERTENSIVE DRUGS IN SHRI SATHYA SAI MEDICAL COLLEGE & RESEARCH INSTITUTE

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Synopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY. Aileen Milne PhD, Manager, Safety Pharmacology

PHYSICIAN ORDERS. Page 1 of 6. Provider Initial: Esophagectomy Preoperative [ ] Height Weight Allergies

Premedication with alpha-2 agonists procedures for monitoring anaesthetic

Metacam 1.5 mg/ml oral suspension for dogs

THE ACTIVITIES OF ANTHELMINTIC INFUSA OF PAPAYA SEEDS (CARICA PAPAYA L.) AGAINST WORMS ASCARIS SUUM (STUDY IN VITRO)

Irish Medicines Board

Feline blood transfusions: preliminary considerations

IOWA STATE UNIVERSITY Institutional Animal Care and Use Committee. Blood Collection Guidelines

Please refer to Table 1 Dosage and Treatment Schedule TABLE 1 Species Product Number of Tubes Cats. Rabbits or Advantage 40 for Cats

PERFUSION OF ISOLATED DOG SKIN*

Journal of Chemical and Pharmaceutical Research

PDF of Trial CTRI Website URL -

Assessing antihypertensive adherence with therapeutic drug monitoring Erika SW JONES, Maia LESOSKY, Marc BLOCKMAN, Sandra CASTEL, Eric H DECLOEDT,

EPAR type II variation for Metacam

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

SUMMARY OF PRODUCT CHARACTERISTICS. KELAPRIL 2.5 mg, film coated tablets for dogs and cats [FR] KELAPRIL 2,5 film coated tablets for dogs and cats

Sites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site:

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

A New Advancement in Anesthesia. Your clear choice for induction.

Acute Pyelonephritis POAC Guideline

Dosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton

Materials and Methods: Anti-snake venom activities of Asparagus racernosus

Heartworm Disease in Dogs

Role of "-Adrenoreceptors In The Regulation of Fore-Stomach Motility in the Goat

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

Procedure # IBT IACUC Approval: December 11, 2017

Final Report. Project code: P.PSH.0653 Prepared by: Fiona Cotter Troy Laboratories Pty Ltd Date published: July 2014

Health Products Regulatory Authority

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

POST-OPERATIVE ANALGESIA AND FORMULARIES

Public Assessment Report Scientific discussion

SOME OBSERVATIONS ON PECKING IN PIGEONS

SUMMARY OF PRODUCT CHARACTERISTICS

Pain Management in Racing Greyhounds

SUMMARY OF PRODUCT CHARACTERISTICS

MARBOCYL FD SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

Metacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.

6/10/2015. Multi Purpose Canine (MPC) Restraint and Physical Examination PFN: Terminal Learning Objective. Hours: Instructor:

Welcome! 10/26/2015 1

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

Is Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dog Diagnosed With a Degenerative Joint Process?

Gang LING, Ai-jun LIU, Fu-ming SHEN, Guo-jun CAI, Jian-guo LIU, Ding-feng SU 2

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Dr. Omar S. Tabbouche, M.Sc, D.Sc, Pharm.D Head of Pharmacy Department New Mazloum Hospital Tripoli, Lebanon

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

The Guide for the Care and Use of Laboratory Animals, 8th Edition, November Euthanasia. pp

Poultry Science Journal ISSN: (Print), (Online)

Summary of Product Characteristics

Canine Spay and Neuter Services At Manzini Animal Hospital

Fortekor 5 mg. Tablets for Dogs and Cats

Induction of a Transient Chemically Induced Lameness in the Sow. Detection Using a Prototype Embedded Micro-computerbased Force Plate System

HOW TO CITE THIS ARTICLE:

SUMMARY OF PRODUCT CHARACTERISTICS. Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)

Diurnal variation in microfilaremia in cats experimentally infected with larvae of

SUMMARY OF PRODUCT CHARACTERISTICS

Standing sedation with medetomidine and butorphanol in captive African elephants (Loxodonta africana)

LUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification. Telmisartan and Amlodipine Tablets 40 mg/5 mg; 40 mg/10 mg; 80 mg/5 mg and 80 mg/10 mg

Summary of Product Characteristics

PATIENT INFORMATION LEAFLET GENTAMICIN 10MG/ML SOLUTION FOR INJECTION OR INFUSION. and GENTAMICIN 40MG/ML SOLUTION FOR INJECTION OR INFUSION

IJBCP International Journal of Basic & Clinical Pharmacology. Adverse drug effects monitoring of amlodipine in a tertiary care hospital

Preparation and Evaluation of Veterinary 0.1% Injectable Solution of Atropine Sulphate

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 23 January 2008

A COMPARATIVE STUDY OF MIDAZOLAM, PROPOFOL AND DEXMEDETOMIDINE INFUSIONS FOR SEDATION IN ME- CHANICALLY VENTILATED PATIENTS IN ICU

DISSOCIATIVE ANESTHESIA

Medical University of Warsaw Faculty of Pharmacy

Anesthesia Check-off Form

VETERINARY SCIENCE CURRICULUM. Unit 1: Safety and Sanitation

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS VIRBAGEN OMEGA - EN 1

PATIENT INFORMATION LEAFLET

Prevalence of Liver Fluke in Sheep and Goat Slaughtered at Abattoirs in Zaria, Kaduna State, Nigeria

Summary of Product Characteristics

EC-AH-011v1 January 2018 Page 1 of 5. Standard Operating Procedure Equine Center Clemson University

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

Australian College of Veterinary Scientists Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1

Candidate Name: PRACTICAL Exercise Medications & Injections

ASSESSMENT Theory and knowledge are tested through assignments and examinations.

Anesthetic regimens for mice, rats and guinea pigs

SUMMARY OF PRODUCT CHARACTERISTICS

Question 1. Question 2

STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Antihypertensive efficacy of amlodipine in children with chronic kidney diseases

SUMMARY OF PRODUCT CHARACTERISTICS

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

ANNEX III LABELLING AND PACKAGE LEAFLET

Alfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS

SAMPLE. Certificate in Understanding the Safe Handling of Medication in Health and Social Care PRESCRIPTION. Workbook 1 LEGISLATION.

Transcription:

Research Article Vol: 2; Issue: 2 THE STUDY OF HYPOTENSIVE EFFECTS OF AQUEOUS LEAVE EXTRACT OF VERNONIA AMYGDALINA ON NORMOTENSIVE CATS Buraimoh A.A 1 *, Shu aibu H.O. 1, Ojo S.A. 2 and Bako I.G. 3 1 Department of Human Anatomy, Faculty of Medicine, Ahmadu Bello University, Samaru, Zaria, Nigeria. 2 Department of Veterinary Anatomy, Faculty of Veterinary Medicine, Ahmadu Bello University, Samaru, Zaria, Nigeria. 3 Department of Human Physiology, Faculty of Medicine, Ahmadu Bello University, Samaru, Zaria, Nigeria. Date Received: 2 nd Feb 2014 Date of Accepted: 6 th Feb 2014 Date Published: 11 th Feb 2014 Abstract: The hypotensive effects of aqueous leave extract of Vernonia amygdalina were evaluated on normotensive cats. The cats used for this experiment were injected with the aqueous leave extract of Vernonia amygdalina at doses of 1mg/ml, 10mg/ml and 100mg/ml through a canula inserted in the femoral artery. Acetylcholine has a relaxing effect on the blood pressure. Atropine, a receptor blocker was then administered along with the standard drug and the leave extract in order to determine the potency of its blocking effect on the leave extract and standard drug. The leave extract of Vernonia amygdalina produced a significant decrease in blood pressure. The 1mg/ml of the leave extract exhibited more effective response; however the standard drug Acetylcholine showed a greater potency than the extract. The blood pressure reducing effects of both drug and extract was inhibited by Atropine. Based on our observations, we therefore conclude that the aqueous leave extract of Vernonia amygdalina produced significant reduction in cat blood pressure and could be use in the management of hypertension. Keywords: Hypotensive, Blood pressure, Vernonia amygdalina, Normotensive, Hypertension, Effects, Aqueous extract, Cats. Introduction Hypertension or high blood pressure, generally referred to as blood vessel high blood pressure, could be a chronic medical condition within which the pressure within the arteries is elevated [1]. This requires the heart to work harder than normal to circulate blood through the blood vessels. Blood pressure is summarized by two measurements; beat and pulsation, that depend upon whether or not the heart muscle is acquiring (systole) or relaxed between beats (diastole) and equate to a most and minimum pressure respectively. Normal blood pressure at rest is at intervals; varying of 100-140mmHg systolic (top reading) and 60-90mmHg diastolic (bottom reading). High blood pressure is said to be present if it is persistently at or above 140/90 mmhg. It is also a chronic medical condition in which the blood pressure (BP) in the arteries is elevated. It is classified as either primary (essential) or secondary. About 90 to 95% of cases are termed primary HTN, 88

which refers to high BP for which no medical cause can be found[2] The remaining 5 to 10% of cases, called secondary HTN, are caused by other conditions that affect the kidneys, arteries, heart, or endocrine system [3]. Hypertension is one of the growing important threats of the health of adults in Sub Saharan Africa. Various data that have been published from Nigeria and other countries in Sub Saharan Africa have shown a high (and rising) prevalence of hypertension generally, and a consistently higher prevalence in urban than in rural areas. They have also shown low rates of treatment and control; and when not properly controlled, it could lead to life wasting conditions like stroke, and other cardiovascular complications [4]. Plants have played a significant role in maintaining human health and improving the quality of human life for thousands of years, they have served humans well as valuable components of medicines, seasonings, cosmetics and dyes [5]. Approximately, 100 herbs are reported in the literature to have an effect on blood pressure [6, 7, 8].Although, few of these herbs were describe as having potential to increase blood pressure, the majority of the agents show an ability to decrease blood pressure. Ginseng (Panax Ginseng) is the only commonly used herbs that may produce either a hypotensive or hypertensive effect which are dose-dependent. Vernonia amygdalina, a member of the Asteraceae family, is a small shrub that grows in the tropical Africa. V. amygdalina typically grows to a height of 2--5 m.the leaves are elliptical and up to 20 cm long. Its bark is rough. Vernonia amygdalina is commonly called bitter leaf in English because of its bitter taste. African common names include grawa (Amharic), ewuro (Yoruba), etidot (Ibibio), onugbu (Igbo), ityuna (Tiv), oriwo (Edo), chusar-doki (Hausa), muluuza (Luganda), labwori (Acholi),and olusia (Luo) Ndolé (cameroon) [9,10]. Vernonia amygdalina is well known as a medicinal plant with several uses attributed to it, including for diabetes, fever reduction and recently a non-pharmaceutical solution to persistent fever, headache and joint pain associated with AIDS(an infusion of the plant is taken as needed) [11]. The purpose of this experiment was to evaluate the hypotensive effects of aqueous leave extract of Vernonia amygdalina on normotensive cats. MATERIALS AND METHODS: Chemicals and Drugs: The chemical and drugs used in this experiment were of analytical grade Heparin, sodium Thiopentane, Atropine, Acetylcholine, syringes were obtained from Zaria. Plant materials: The leaves of Vernonia amygdalina were collected within Ahmadu Bello University, Samaru, Zaria and were identified by Taxonomist in the Department of Biological Sciences and authenticated voucher samples Voucher no 9176; and later deposited in the research laboratory of National Research Institute for Chemical Technology (NARICT), Zaria, Nigeria. Extract preparation: The Vernonia amygdalina leaves were washed thoroughly, shade dried and grounded into powder. The aqueous extraction was done with the aid of Soxhlet extractor in the research laboratory of National Research Institute for Chemical Technology (NARICT), Zaria, Nigeria. Experiment Design: The cats used were anaesthetised by injecting thiopentane sodium through intraperitoneal route and soon lost consciousness within 10 to 25minutes after administration. They were properly brought to the dissecting table and their limbs were tied. Intravenous injection was made into the left femoral vein and blood pressure was recorded from the left femoral artery. The left femoral vein was exposed and tied with peripheral ligature; and also the right carotid artery was exposed and cannulated for blood pressure measurement. Heparin was injected through before canulating the right carotid artery in order to act as anti-coagulant, thereby preventing blood clot. The basal blood pressure was recorded on a filter paper of the micro-dynamometer after the administration of the heparinized normal saline to prevent blood clothing.the right Carotid artery was also exposed and cannulised for the blood pressure measurement. Normal saline, Atropine, Acetylcholine (Ach) and the extract was administered through the canula inserted through the left femoral vein. The speed and sensitivity of the machine were 95mm/minute and 1 respectively. The dosages of Vernonia amygdalina extract administered for each cat was at 1ml/mg, 10ml/mg and 100ml/mg. Flushing was properly done after every administration of extract and drugs (Ach and Atropine) until it was brought back to normal. Mean Arterial Blood pressure (MAP) was calculated as = [(2xdiastolic) + systolic]/3. Statistical Analysis: All data were expressed as Mean ±S.E.M. The data obtained were analyzed using one way analysis of variance (ANOVA) and Turkey-Kramer posthoc test for multiple comparisons. The P-Value less than 0.05 (P<0.05) was to be accepted as statistically significant [12]. 89

RESULTS AND DISCUSSION: Table 1: Comparison between Normal Basal Rhythm, Acetylcholine and Aqueous leave extract of Vernonia amygdalina. Blood pressure (mmhg) Normal Basal rhythm (Mean±SEM) Acetyl choline (Mean±SEM) Aqueous extract of Vernonia amygdalina (Mean±SEM) 1mg/ml 10mg/ml 100mg/ml Systolic pressure 64.5 ± 3.5 40.0±0.88* 32.6±0.45* 43.1±0.5 NS 48.4±3.11* Diastolic pressure 38.0±3.5 22.5±0.35* 20.0±1.85* 30.9±1.1 NS 24.25±3.41* Pulse pressure 26.5±3.5 17.5 ±0.35* 12.6±0.63* 12.2±1.76* 24.2±5.13 NS Mean Arterial Blood pressure 46.8±2.3 28.3±0.35* 24.2±1.33* 35.0±2.28* 32.3±3.0* (MAP) * means Significant at P 0.05; NS means Not Significant at P 0.05 ; Mean Arterial Blood Pressure (MAP) = [(2xdiastolic) + systolic]/3. OR MAP = diastolic pressure+ 1/3 pulse pressure Table 2: Drug Antagonistic Studies Drug + aqueous extract 0.1ml Atropine + 0.05 mlach 0.1 ml Atropine + 0.8 ml extract 0.1 ml Atropine + 0.8 ml extract (After 3 min interval) Mean±SEM) [1mg/ml] (After 3 min [1mg/ml] (No time interval) Blood Pressure mmhg) interval)(mean±sem) Mean±SEM Systolic pressure 34.50±0.35 32.5±0.35 32.5±0.35 Diastolic pressure 23.0±0.71 28.5±3.19 24.5±0.35 Pulse pressure 11.5±0.35 4.0±0.35 8.0±0.35 Mean Arterial 26.83±0 29.83±0.25 27.17±0.00 Blood(MAP) pressure Mean Arterial Blood Pressure (MAP) = [(2xdiastolic) + systolic]/3 ; OR MAP = diastolic pressure+ 1/3 pulse pressure 90

NB = Normal basal rhythm; Fig. 1: Tracing of Normal Saline P = Point of administration; NB= Normal basal rhythm Fig. 5: Tracing of Acetylcholine, the standard drug with a volume of 0.05 mls P = Point of administration NB =Normal basal rhythm Fig. 2: Tracing of 1mg/ml of aqueous leave extract of vernonia amygdalina with volumes of 0.8mls P =Point of administration; NB= Normal basal rhythm Fig. 6: Tracing of Drug antagonistic studies 0f 0.8ml of 1mg/ml of aqueous extract of Vernonia amygdalina blocked by 0.1 ml Atropine P=Point of administration; NB=Normal basal rhythm; Fig. 3: Tracing of 10mg/ml of aqueous leave extract of vernonia amygdalina with volumes of 0.8mls. P =Point of administration; NB =Normal basal rhythm Fig. 7: Tracing of Drug antagonistic studies of 0.05 ml acetylcholine blocked by 0.1 ml of Atropine P = Point of administration; NB= Normal basal rhythm Fig. 4: Tracing of 100mg/ml of aqueous extract of Vernonia amygdalina with volume of 0.8mls Blood pressure values: The blood pressure values of the cat for normal saline, the injected standard drugs and aqueous leave extract of Vernonia amygdalina as obtained from the micro-dynamometer are shown in the Tables 1-2 and Figures. 1-6. One centimeter (1cm) of the standard ruler used in measuring the systolic and diastolic blood pressure change corresponds to 10mmHg pressure change in glass sphygmomanometer. On the tracing the values from the baseline to the lowest border of the tracing represent the diastolic pressure while from the baseline to upper border represent the systolic pressure. The results of blood pressure values were analyzed by comparing the mean ± SEM of normal basal rhythm, acetylcholine and aqueous leave extract of Vernonia amygdalina using one way analysis of variance as shown in the tables 1&2. 91

The blood pressure systolic for normal basal rhythm was 64.5 ± 3.5, for Acetylcholine was 40.0±0.88; and for aqueous leave extract of Vernonia amygdalina at doses of 1mg/kg, 10mg/kg and 100mg/kg was 32.6±0.45, 43.1±0.45 and48.4±3.11 respectively. There were statistically significant differences in the observed decrease in systolic when compared with the control except for the extract at the dose of 10mg/kg that had a decrease value that was not statistically significant (Table1). The diastolic blood pressure for the normal basal rhythm was 38.0±3.5, that of Acetylcholine was 22.5±0.35; and for aqueous leave extract of Vernonia amygdalina at doses of 1mg/kg, 10mg/kg and 100mg/kg were 20.0±1.85, 30.9±1.1 and 24.25±3.41 respectively. There were statistically significant differences in the decrease observed in the diastolic blood pressure when compared with normal basal rhythm at P 0.05 except for the extract at the dose of 10mg/kg that had a decrease value that was not statistically significant at P 0.05 (table1). The pulse pressure for normal basal rhythm was 26.5±3.5, that of Acetylcholine was 17.5±0.35; and for aqueous leave extract of Vernonia amygdalina at doses of 1mg/kg, 10mg/kg and 100mg/kg were 12.6±0.63, 12.2±1.76 and 24.2±5.13 respectively. The decrease observed in the pulse pressure was statistically significant at P 0.05 except for the extract at the dose of 100mg/kg that was not statistically significant at P 0.05(Table 1). The mean arterial blood pressure for normal basal rhythm was 46.8±2.3, that of Acetylcholine was 28.3±0.35; and for aqueous leave extract of Vernonia amygdalina at doses of 1mg/kg, 10mg/kg and 100mg/kg were 24.2±1.33, 35.0±2.28 and 32.3±3.0 respectively. The decrease in the mean arterial blood pressure observed for acetylcholine and the extract at doses 1mg/kg, 10mg/kg and 100mg/kg were statistically significant at P 0.05 when compared with the normal basal rhythm (Table 1). In the drug antagonist studies in Table 2, Atropine blocked the effects of both Acetylcholine and the leave extract (Figures 6&7). Atropine tend to have stronger blocking effects on acetylcholine that the leave extract (see table 2 and figures 6&7). Adequate control of blood pressure and blood glucose with drugs and other measures like dietary and life style regulations are necessary to retard the progression of cardiovascular complications associated with hypertension and diabetes [13, 14].Unfortunately, there are compliance problems with recommended drug schedules. This is complicated by the fact that the drug regimes may not be appropriate in developing countries like Nigeria for various cultural and socio-economic reasons associated with poverty and illiteracy. Furthermore, the majority of the populations in most of these countries especially those in the rural areas do not have access to conventional medical facilities, so they rely mainly on traditional medicine for their health care needs. The most widely used antihypertensive drugs have been criticized, particularly in diabetics, because of their various adverse effects [14]. Reports showed that Vernonia. amygdalina had hypoglycaemic effects in human and animal experimental subjects [15,16,17]. Blood pressure depends on several factors which include heart rate, stroke volume, and peripheral resistance. Agents that lower blood pressure do so via one or a combination of several blood pressure regulatory mechanisms. The results of this study revealed that aqueous leave extracts of Vernonia amygdalina produced a dose-dependent decrease in arterial blood pressure (had significant blood pressure lowering effects) of normotensive cats(tables 1, Figures 2-4). The blood pressure (systolic and diastolic), pulse pressure and mean arterial blood pressure in all three doses (1, 10 and 100mg/ml) of the aqueous leaves extract of Vernonia amygdalina decreased significantly at P< 0.05 when compared with the normal basal rhythm with the exceptions of the diastolic and systolic pressures of 10mg/ml of the extract and the pulse pressure of 100mg/ml of the leave extract that was not statistically significant at P > 0.05 when compared with the normal basal rhythm(table 1). The tracings in Figures 2-4 showed the blood pressure lowering effects (hypotensive) of Vernonia amygdalina. The standard drug (Acetylcholine) also compared with the normal basal rhythm decreased significantly in the blood pressure (systolic and diastolic), pulse pressure and mean arterial blood pressure as shown in Table 1 and Figures 1&5 above. In the drug antagonistic studies in Table 2 above, Atropine blocked the effects of the leaf extract, as well as, that of acetylcholine but with very little difference. This indicates that atropine has blocking effects on both the drug and the leaf extract as seen in Figures 6&7. The standard drug, Acetylcholine, when compared with the normal basal rhythm, the blood pressure (systolic and diastolic), pulse pressure and mean arterial pressure decreased statistically significant at P<0.05(see Table 1, Figures 1&5). The lowering blood pressure effects observed via the extract was completely blocked by Atropine (Fig. 6).Therefore, the hypotensive action of Vernonia amygdalina may be mediated through cholinoceptors as cholinergic antagonist, because Atropine blocked the effects of leave extract (Fig.6). From this study, it can be inferred that, Vernonia 92

amygdalina leave extract has an appreciable blood pressure lowering effects (hypotensive) on normotensive cats. CONCLUSION: Based on our observations, we therefore conclude that the aqueous leave extract of Vernonia amygdalina produced significant reduction in cat blood pressure (hypotensive) and could be a useful tool in the management of hypertension. ACKNOWLEDGMENT: The authors wish to acknowledge the immense support given by Vice Chancellor of Ahmadu Bello University, Zaria and cannot forget the contributions of staff of Pharmacology Laboratory of the Faculty of Pharmaceutical Science, Ahmadu Bello University, Zaria, Nigeria. REFERENCES: 1. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C, Green, L.A., Izzo, J.L. Jr, Jones, D.W., Materson, B.J. & Oparil, S. (2003)."Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure Hypertension 42(6): 1206-52. 2. Carretero, O.A. & Oparil, S. (2000). Essential hypertension.part I: Definition and etiology. Circulation.; 101:329 35. 3. Beevers, G., Lip, G.Y. & O Brien, E. (2001). ABC of hypertension: The patho-physiology of hypertension. BMJ; 322:912 6. 4. Lioyd-Jones, D., Adams, R. & Carnethon, M. (2009). Heart disease stroke statistics; Circulation, American Heart of Association Journal, 119: e21-81. 5. Singh, K.K. & Kumar, K. (1999). Ethnotherapeutics of some medicinal plants used as antipyretic agents among the tribes of India, Journal of Economic Taxonomy and Botany, 23 (1).135-141. 6. Zhou, Y.P. (1998). Chinese materia a medica chemistry, pharmacology and Applications. Harwood Academic publishers. 316-317. 7. Huang, K. (1993). The Pharmacology of Chinese Herbs. CRC Press;229-232. 8. http:// www. natural database.com; Natural Medicine Comprehensive database. 9. Kokwaro, J. (2009). Medicinal Plants of East Africa 3rd ed. Nairobi, Kenya: University of Nairobi Press. ISBN 9966-846-84-0. 10. Ijeh, I.I. & Ejike, C.E.C.C. (2011)."Current perspectives on the medicinal potential of Vernonia amygdalina Del". J Med Plant Res 5 (7): 1051 1061. 11. http://en.wikipedia.org/wiki/vernonia. 12. Betty, R.K. & Jonathan, A.C. (2003). Essential Medical Statistics. 2nd Edn., Blackwell science USA, pp: 15-409. 13. Swales, J.D. (1990). Hypertension in diabetes. Practical Diabetes Digest 1(3), 92-95. 14. Mbanya, J.C. (1993). How to treat hypertension in diabetes. International Diabetes Digest1; 4(4): 107-109. 15. Ogbuokiri, J.E. & Ekpechi, D.L. (1989). Antihyperglycaemic activity of Vernonia amygdalina on healthy adult volunteers. Clinical Pharmacy and Herbal Medicine; 5(3): 18-21. 16. Gyang, S.S., Nyam, D.D. & Sokomba, E.N. (2004). Hypoglycaemic Activity of Vernonia amygdalina (chloroform extract) in Normoglycaemic and Alloxan-Induced Hyperglycaemic Rats. Journal of Pharmacy and Bioresources; 1(1): 61-66. 17. Taiwo, I.A., Odeigah, P.G.C. & Ogunkanmi, L.A. (2009). The glycaemic effects of Vernonia amygdalina and V. tenoreana with tolbutamide in rats and the implications for the treatment of diabetes mellitus. Journal of Scientific Research and development; 11: 122-130. 93